World-First Nod For Yuhan's Lung Cancer Drug, In Korea

Eyes Now On J&J's Global Combo Trial

Red Approved Stamp with Wooden handle Rubber Stamper Isolated on White Background.
LECLAZA Becomes Korea’s 31st Approved New Drug • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from South Korea

More from Focus On Asia